[Cerebrotendinous xanthomatosis--a treatable metabolic disorder].
Sperhake
J P
JP
Matschke
J
J
D000328:Adult; D001921:Brain / Q000473:pathology; D002635:Chenodeoxycholic Acid / Q000627:therapeutic use*; D004083:Cholestanol / Q000097:blood; D002784:Cholesterol / Q000097:blood; D002869:Chromosome Aberrations; D003937:Diagnosis, Differential; D005260:Female; D005500:Follow-Up Studies; D005808:Genes, Recessive; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D009460:Neurologic Examination; D013250:Steroid Hydroxylases / Q000172:deficiency; D016896:Treatment Outcome; D014280:Triglycerides / Q000097:blood; D019294:Xanthomatosis, Cerebrotendinous / Q000175:diagnosis / Q000188:drug therapy* / Q000235:genetics / Q000401:mortality
D014280:Triglycerides; D002635:Chenodeoxycholic Acid; D004083:Cholestanol; D002784:Cholesterol; D013250:Steroid Hydroxylases